Nova Eye Medical Ltd
Company Profile
Business description
Nova Eye Medical Ltd is a medical technology company that develops, manufactures, and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of its revenue from the United States of America.
Contact
107 Rundle Street
Kent Town
AdelaideSA5067
AUST: +61 883620193
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2026
Employees
301
Stocks News & Analysis
stocks
CSL remains favourite, but biotech field broadening
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,822.40 | 19.50 | -0.22% |
CAC 40 | 7,696.27 | 58.28 | -0.75% |
DAX 40 | 23,787.45 | 146.68 | -0.61% |
Dow JONES (US) | 44,828.53 | 344.11 | 0.77% |
FTSE 100 | 8,822.91 | 0.29 | -0.00% |
HKSE | 23,864.78 | 51.28 | -0.21% |
NASDAQ | 20,601.10 | 207.97 | 1.02% |
Nikkei 225 | 39,560.88 | 250.00 | -0.63% |
NZX 50 Index | 12,764.95 | 1.65 | -0.01% |
S&P 500 | 6,279.35 | 51.93 | 0.83% |
S&P/ASX 200 | 8,584.80 | 18.20 | -0.21% |
SSE Composite Index | 3,471.90 | 0.42 | -0.01% |